16848-19-4

Basic information

• Product Name: 1,2,5,6-di-O-isopropylidene-3-deoxy-3-amino-α-D-glucofuranoside
• Synonyms: 1,2,5,6-di-O-isopropylidene-3-deoxy-3-amino-α-D-glucofuranoside
• CAS NO: 16848-19-4
• Molecular Weight: 259.302
• Mol File: 16848-19-4.mol
• Article Data: 21

Chemical Properties

• CAS DataBase Reference: 1,2,5,6-di-O-isopropylidene-3-deoxy-3-amino-α-D-glucofuranoside(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,5,6-di-O-isopropylidene-3-deoxy-3-amino-α-D-glucofuranoside(16848-19-4)
• EPA Substance Registry System: 1,2,5,6-di-O-isopropylidene-3-deoxy-3-amino-α-D-glucofuranoside(16848-19-4)

Safety Data

• Hazardous Substances Data: 16848-19-4(Hazardous Substances Data)

Upstream product

• 141903-85-7 3β-<((trifluoromethyl)phenylmethyl)imino>-3-deoxy-1,2:5,6-di-O-isopropylidene-D-glucofuranose 
• 380911-39-7 1,2:5,6-di-O-isopropylidene-3-triflyl-α-D-glucofuranose 
• 27581-57-3 3-azido-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 4572-32-1 3-O-p-bromobenzenesulfonate of 1,2:5,6-di-O-isopropylidene-α-D-allofuranose 
• 82893-04-7 C₃₀H₃₄O₆P⁽¹⁺⁾*N₃^(1-) 
• 68922-46-3 (1,2;5,6-Di-O-isopropyliden-α-D-glucofuranos-3-yloxy)phosphonium-iodid 
• 6027-62-9 3-deoxy-3-iodo-1,2:5,6-di-O-isopropylidene-α-D-allofuranose 
• 13964-23-3 3-azido-3-deoxy-1,2:5,6-di-(O-isopropylidene)-α-D-glucofuranose 
• 3253-75-6 1,2:5,6-di-O-isopropylidene-3-O-tosyl-α-D-glucofuranoside 
• 16667-96-2 1,2,5,6-di-O-isopropylidene-α-D-glucofuranose-3-O-(S-methylxanthate) 
• 141903-84-6 3-((4-methoxyphenyl)telluro)-3-deoxy-1,2:5,6-di-O-isopropylidene-D-glucofuranose 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 3253-75-6 1,2,5,6-di-O-isopropylidene-3-O-(p-toluenesulfonyl)-α-D-allofuranose 
• 14686-89-6 (1,2:5,6)-di-O-isopropylidene-D-gulose 

Downstream Products

• 34379-43-6 3-acetamido-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-allofuranose 
• 113455-55-3 O¹,O²;O⁵,O⁶-diisopropylidene-3-salicylideneamino-3-deoxy-α-D-allofuranose 
• 81645-62-7 3-benzoylamino-O¹,O^2;O⁵,O⁶-diisopropylidene-3-deoxy-α-D-allofuranose 
• 60302-10-5 3-amino-3-deoxy-D-allose 
• 180404-49-3 3-deoxy-1,2:5,6-di-O-isopropylidene-3-(3-phenylthioureido)-α-D-allofuranose 
• 180404-53-9 3-deoxy-1,2:5,6-di-O-isopropylidene-3-(3-phenylthioureido)-α-D-glucofuranose 
• 7508-81-8 [(3aR,5S,6S,6aR)-5-((R)-2,2-Dimethyl-[1,3]dioxolan-4-yl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl]-carbamic acid benzyl ester 
• 214918-32-8 [(3aR,5S,6S,6aR)-5-((R)-1-Hydroxy-ethyl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl]-carbamic acid benzyl ester 
• 37073-89-5 [(3aR,5S,6S,6aR)-5-((R)-1,2-Dihydroxy-ethyl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl]-carbamic acid benzyl ester 
• 214918-31-7 [(3aR,5S,6S,6aR)-5-((S)-1-Hydroxy-2-iodo-ethyl)-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl]-carbamic acid benzyl ester 
• 451505-53-6 Acetic acid (3R,4S,5S,6R)-2,5-diacetoxy-4-benzyloxycarbonylamino-6-methyl-tetrahydro-pyran-3-yl ester 
• 451505-46-7 Toluene-4-sulfonic acid (R)-2-((3aR,5S,6S,6aR)-6-benzyloxycarbonylamino-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-2-hydroxy-ethyl ester 
• 214918-34-0 Acetic acid (2R,3R,4S,5S,6R)-5-acetoxy-4-benzyloxycarbonylamino-2-(bis-benzyloxy-phosphoryloxy)-6-methyl-tetrahydro-pyran-3-yl ester 

Relevant articles and documents

NEW SYNTHETIC "TRICKS". (Et3NH)(Sn(SPh)3) AND Bu2SnH2, TWO USEFUL REAGENTS FOR THE REDUCTION OF AZIDES TO AMINES

Treatment of Sn(SPh)2 with PhSH and Et3N affords a tin(II) complex, soluble in organic solvents, wich is the best reducing agent for azides reported so far.Bu2SnH2, although not so reactive, also shows several advantages with regard to the standard reducing agents for azides, such as its solubility in most solvents or its scarce reactivity with water.

Gabriel-Cromwell aziridination of amino sugars; chiral ferrocenoyl-aziridinyl sugar synthesis and their biological evaluation

N-sugar substituted chiral aziridines were synthesized via Gabriel-Cromwell reaction. Novel pure diastereomers of aziridine derivatives (4 diastereomers) were readily obtained in high yields and their structures were confirmed by means of 1H NM

A method for preparing N-alkylated kanosamines from diacetone D-glucose

The aminoglycoside (AG) antibiotics have seen a resurgence in their clinical use given the increase in multi drug resistant bacterial infections. Campaigns to generate novel analogs show promise that structural modification can lead to compounds with improved pharmacological properties. The results described herein include a new method to synthesize mono-, di-, and mixed N-alkylated kanosamine sugars and their elaboration into novel glycosides that inhibit bacterial protein synthesis in vitro.

Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents

The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disorder herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases su